Research progress on caffeine citrate in the treatment of neonatal respiratory distress syndrome
10.3760/cma.j.issn.1673-4912.2022.09.012
- VernacularTitle:枸橼酸咖啡因治疗新生儿呼吸窘迫综合征的研究进展
- Author:
Lin YAN
1
;
Hua MEI
;
Chunzhi LIU
Author Information
1. 内蒙古医科大学附属医院新生儿科，呼和浩特 010050
- Keywords:
Caffeine citrate;
Neonatal respiratory distress syndrome;
Preterm infants
- From:
Chinese Pediatric Emergency Medicine
2022;29(9):721-724
- CountryChina
- Language:Chinese
-
Abstract:
Neonatal respiratory distress syndrome is typically characterized by progressive exacerbation of respiratory distress shortly after birth, which is more common in preterm infants and has a high disability and mortality rate.Caffeine citrate has been used in the treatment of premature infants with respiratory distress syndrome to enhance the contraction of the diaphragm and optimize the function of respiratory muscles to accelerate the recovery of spontaneous breathing.This review summarized the use of caffeine citrate in premature infants with respiratory distress syndrome.
